INTRODUCTION
Skeletal muscle is a major target tissue for insulin. A role for diacylglycerol (DAG)/protein kinase C (PKC) signalling during insulin action in skeletal muscle has been suggested by a number of studies [1] [2] [3] [4] [5] [6] . PKC activation, however, may involve one or more PKC isoforms, and, save for limited early studies of PKC-/ and -e [2, 3] , there is relatively little information on which PKC isoforms are translocated in response to insulin treatment in skeletal muscles of the mature rat. Importantly, there are no reports on PKC-O, a newly recognized major PKC isoform in skeletal muscle [7] , nor on PKC-a, another relatively abundant PKC isoform in this tissue. In this study, we evaluated the effects of insulin and/or phorbol esters on the subcellular distribution of PKC-0, PKC-a, PKC-,/ and PKC-e in rat soleus (red fibres), gastrocnemius (mixed fibres) and tensor fascia lata (white fibres) muscles.
MATERIALS AND METHODS In vitro studies
As described previously [2, 3] , soleus muscles from fed 150 g male Holtzmann Sprague-Dawley rats were ligated, stretched and equilibrated at 37°C under 95 % 02/5 % CO2 in glucose-free Krebs-Ringer bicarbonate (KRB) buffer containing 0.1 % BSA and 2 mM sodium pyruvate. Insulin (100 nM) (Elanco) or phorbol 12-myristate 13-acetate (PMA) (500 nM) (Sigma) was then added and incubation was continued for the indicated times. In each case, one treated soleus muscle was directly compared with the contralateral control soleus muscle, and the change in PKC due to treatment was calculated as a percentage of the control. In some experiments, metabolic integrity and responsiveness to insulin were evaluated by incubating solei for 60 min in KRB medium containing 5 mM glucose, [U_14C]Dglucose (1 ,uCi/ml) (NEN/Dupont) and [6-3H] L-glucose (1 ,uCi/ ml) (NEN/Dupont) to correct for non-specific uptake. Total uptake of D-glucose and incorporation into glycogen and lipids were calculated on the basis of the specific radioactivity of medium D-glucose (the latter incorporation rates are probably underestimated because of isotope dilution by intracellular metabolites). of phorbol esters. Increases in membrane-associated PKC-0, PKC-a, PKC-,8 and PKC-e were also observed in rat gastrocnemius muscles after insulin treatment in vivo. Our findings suggest that PKC-6, like other diacylglycerol-sensitive PKC isoforms (a, / and e), may play a role in insulin action in skeletal muscles.
In vivo studies
As described previously [3] , rats were injected intramuscularly every 30 min with 0.25 unit of insulin in saline, and intraperitoneally with 1.5 ml of 10% (w/v) glucose in saline to increase serum insulin to maximally effective levels (see [3] ) and to maintain blood sugar, over a 30-120 min period. Control rats were injected identically with saline at the same times.
Western-blot analyses Cytosol and membrane fractions were prepared and subjected to immunoblot analysis as described previously [8] , except that nonspecific binding sites were blocked with polyvinyl alcohol (see [9] ) for studies of PKC-a, -/3, 4, and -e; manufacturer's instructions (Transduction Laboratories) and ECL (Amersham) were used for the PKC-6 assay. In all cases, equal amounts of protein from control and treated samples were analysed simultaneously on the same blot. The polyclonal antisera used for detecting PKC-ax, -e, and -d were obtained from Life Sciences Lab. Anti-PKC-,8 serum was obtained from Drs. Bryan Roth and John Mehegan (see [2] [3] [4] 8, 10] ). The monoclonal antibody used for detecting PKC-0 was from Transduction Labs. As described previously [8] , specificities for PKC-a, -/3, 4, and -e antisera were verified (a) by loss of immunoreactivity when assays were conducted with added immunogenic peptide (see below), and (b) by blotting recombinant PKCs a., /3, y, 8 assayed in the presence of the immunizing peptide ( Figure 1 ). Peptide competition studies were not possible for PKC-0; however, only a single 80 kDa immunoreactive band was founld in muscle, but not in rat brain, adipocytes, liver and heart. Approximate apparent molecular masses (relative to the migration of protein standards) of PKCs a, /3, and on SDS/PAGE were 80, 80, 95 and 80 kDa respectively. Approximate ratios of total cytosolic immunoreactive PKC to total membrane immunoreactive PKC in control muscles were 3-4: 1 for PKCs a, , and e, and 1:1 for PKC-6. The presence of mRNAs for PKC-a, -e and -0 in rat skeletal muscle has been reported previously [7] . The presence of PKC-/G mRNA in rat skeletal muscle, albeit in amounts apparently less than other PKC mRNAs (in general, exposure times for autoradiography were approximately 4-fold longer for PKC-/3 mRNA analyses, as compared with PKC-a mRNA and PKC-e mRNA using probes of similar specific radioactivities), was confirmed, both by Northern-blot analysis (data not shown) and by ribonuclease protection assay (see accompanying paper i.e. ref. [11] ).
In vitro studies In the soleus muscle, insulin provoked rapid, biphasic increases in membrane contents of PKC-a, -/3, -e and -0, with initial peaks Figure 3 and Table 1 ). As shown in Table 2 , the soleus muscle preparations that were used in all the present experiments in vitro responded well to insulin, in terms of total glucose uptake and incorporation into lipids and glycogen. For comparison, results from incubations of rat hemi-diaphragms are shown, and similar uptake and incorporation rates were observed (Table 2) . Also, in other in vivo studies (data not shown) in which rats were studied during euglycaemic-hyperinsulinaemic clamp conditions, total glucose uptake rates into the soleus and diaphragm were remarkably similar to those observed in vitro, i.e. approximately 3000 nmol/g of tissue per 60 min. In similar euglycaemic-hyperinsulinaemic clamp studies, the uptake of non-metabolizable 2-deoxyglucose was also found to be approximately 3400 nmol/g of tissue per 60 min as compared with the basal uptake rate of approximately 1200 nmol/g of tissue per 60 min [12] . Table 3 Effects of Insulin treatment in vivo on membrane contents of PKC-oa, PKC-/I, PKC-e and PKC-0 in rat gastrocnemius muscles Rats were treated for indicated times, and membrane fractions were analysed for immunoreactive PKC isoforms as described in the Materials and methods section. P values (in brackets) was determined by paired ttest. Abbreviation: N.S., not significant. 
DISCUSSION
In soleus, gastrocnemius and tensor fascia lata muscles, insulin provoked increases in membrane contents of PKC-a, -/?, -e and/or -0, apparently via translocation from the cytosol. Since DAG contents and membrane PKC enzyme activities of the soleus and gastrocnemius muscles are also increased by comparable insulin treatments in vitro and/or in vivo [2, 3] phosphatidylcholine (PC) and, to a lesser extent, phosphatidylinositol (PI)-glycans (see [13, 15] ). The secondary increases in membrane PKC probably reflect both de novo phospholipid-DAG synthesis in the endoplasmic reticulum, as well as replenishment and continued hydrolysis of PC and PI-glycans, thus generating DAG (and possibly other lipids) in the plasma membrane (see [8, [13] [14] [15] ). The multiple sources of DAG during insulin action, along with other factors, may contribute to compartmentalization and differences in specific PKC isoform translocation.
Although insulin-induced increases in membrane-associated PKC-a, -/3, -e and -0 were similar in certain circumstances (e.g. in the soleus incubated in vitro), greater variability in changes of these isoforms was observed in other circumstances (i.e. in certain of the more prolonged in vivo studies). The latter variability may reflect greater depletion of insulin-sensitive PKC pools and/or time-dependent changes in signalling through multiple phospholipid pathways during ongoing insulin treatment in vivo. More detailed studies will be needed to resolve these issues.
It should be noted that the presently observed effects of insulin on apparent PKC translocation in the soleus muscle in vitro, as well as those observed previously in isolated adipocytes [4, 8] , occurred in the absence of extracellular glucose. It is therefore clear that these effects of insulin on PKC cannot be due to glucose transport-induced increases in DAG production. This conclusion also follows from the fact that the initial peaks in membrane PKC at 1-2 min of insulin treatment would be expected to precede changes in glucose transport. It should also be noted that insulin increased membrane levels of 'novel', Ca2+-independent PKC isoforms (6 and e), as well as 'conventional', Ca2+-dependent PKC isoforms: this rules out the possibility that simple alterations in Ca2+ can account for insulin-induced PKC translocation.
The stimulatory effects of insulin on the apparent translocation of PKC-0 are noteworthy, as this PKC isoform is particularly abundant in, and is relatively specific for, skeletal muscle [6] .
From the present results, it would appear that this PKC isoform, as well as PKC-a, -, and -e, may play an important role in insulin action in muscle. Further studies are needed to determine which biological processes are altered by insulin-sensitive PKC isoforms.
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